MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Persistent head dyskinesias following STN DBS in Parkinson’s disease resolve using directionality

C. vander Linden, C. Bogaert-Miclaus, D. Colle (Ghent, Belgium)

Meeting: MDS Virtual Congress 2020

Abstract Number: 1376

Keywords: Deep brain stimulation (DBS), Dyskinesias, Parkinsonism

Category: Surgical Therapy: Parkinson's Disease

Objective: To control subthalamic nucleus deep brain stimulation (STN DBS) induced dyskinesias in Parkinson’s disease (PD) using directionality.

Background: Levodopa-induced dyskinesias (LID) frequently occur in PD patients, particularly in those with motor fluctuations. STN DBS diminishes motor fluctuations and also dyskinesias, allowing anti-PD medication reduction. However, persistent dyskinesias may be induced by STN DBS and difficult to control. We describe four PD patients, who pre-operatively exhibited bothersome LID of the head. The head dyskinesias re-occured post-operatively when using particular DBS settings and were resolved using directionality.

Method: 4 patients  (1 woman, age 54 and 3men, ages 61, 61 and 68, mean duration of disease at time of surgery: 12 years), with LID of the head before surgery were implanted with directional leads (Vercise Cartesia™, Boston Scientific). Lead localization was determined based on postoperative images (CT scan and rotational fluoroscopy). The DBS settings were analyzed using Brainlab elements and GuideTM XT. The programmed parameters were selected through detailed contact mapping, searching for optimal respons, while avoiding side effects.

Results: After DBS, the mean levodopa dose was reduced from 1200 mg to 625 mg. Certain DBS contacts induced head dyskinesias, which were reproducible even when the anti-PD medication was stopped for 12 hours, and similar to the LID of the head before surgery.  Using directional stimulation the head dyskinesias subsided, allowing levodopa and dopamine agonists (DA) re-intake for optimal control of the PD symptoms. According to the lead localisation images we hypothesise that the head dyskinesias were provoked by stimulating the dorso–posterior STN.

Conclusion: Post-operative STN DBS head dyskinesias are similar to levodopa-induced dyskinesias, and probably induced by stimulating the dorso-posterior region of the STN.  Current steering may resolve the head dyskinesias, while providing satisfactory therapeutic respons. Patients with pre-operative dyskinesias may best be treated with directional stimulation to avoid so-called brittle dyskinesias (1), although a larger group of patients are needed to confirm our findings.

References: 1. Sriram A, Foote KD, Oyama G, Kwak J, Zeilman PR, Okun MS. Brittle Dyskinesia Following STN but not GPi Deep Brain Stimulation. Other Hyperkinet Mov (N Y). 2014 Jun 5;4:242. doi: 10.7916/D8KS6PPR. eCollection 2014. PMID: 24932426

To cite this abstract in AMA style:

C. vander Linden, C. Bogaert-Miclaus, D. Colle. Persistent head dyskinesias following STN DBS in Parkinson’s disease resolve using directionality [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/persistent-head-dyskinesias-following-stn-dbs-in-parkinsons-disease-resolve-using-directionality/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/persistent-head-dyskinesias-following-stn-dbs-in-parkinsons-disease-resolve-using-directionality/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley